Wall Street brokerages forecast that Colgate-Palmolive (NYSE:CL) will report sales of $3.91 billion for the current fiscal quarter, according to Zacks Investment Research. Seven analysts have made estimates for Colgate-Palmolive’s earnings, with estimates ranging from $3.82 billion to $4.00 billion. Colgate-Palmolive posted sales of $3.72 billion in the same quarter last year, which suggests a positive year over year growth rate of 5.1%. The business is scheduled to announce its next earnings results on Friday, January 26th.

According to Zacks, analysts expect that Colgate-Palmolive will report full year sales of $3.91 billion for the current fiscal year, with estimates ranging from $15.33 billion to $15.56 billion. For the next year, analysts anticipate that the business will report sales of $16.07 billion per share, with estimates ranging from $15.94 billion to $16.27 billion. Zacks’ sales averages are an average based on a survey of sell-side research analysts that cover Colgate-Palmolive.

Colgate-Palmolive (NYSE:CL) last posted its earnings results on Friday, October 27th. The company reported $0.73 EPS for the quarter, meeting the Zacks’ consensus estimate of $0.73. Colgate-Palmolive had a net margin of 15.10% and a return on equity of 2,782.56%. The company had revenue of $3.97 billion during the quarter, compared to analysts’ expectations of $3.94 billion. During the same quarter in the prior year, the company posted $0.73 earnings per share. Colgate-Palmolive’s revenue for the quarter was up 2.8% compared to the same quarter last year.

CL has been the subject of a number of research analyst reports. Zacks Investment Research raised shares of Colgate-Palmolive from a “hold” rating to a “buy” rating and set a $81.00 price target for the company in a report on Monday, October 23rd. Morgan Stanley raised shares of Colgate-Palmolive from an “equal weight” rating to an “overweight” rating and raised their price target for the stock from $75.00 to $84.00 in a report on Monday, September 25th. KeyCorp reaffirmed a “hold” rating on shares of Colgate-Palmolive in a report on Monday, October 16th. Stifel Nicolaus set a $73.00 price target on shares of Colgate-Palmolive and gave the stock a “hold” rating in a report on Sunday, October 29th. Finally, Deutsche Bank initiated coverage on shares of Colgate-Palmolive in a report on Wednesday, December 13th. They issued a “hold” rating and a $75.00 price target for the company. Two investment analysts have rated the stock with a sell rating, fifteen have issued a hold rating and four have issued a buy rating to the company. Colgate-Palmolive has a consensus rating of “Hold” and a consensus target price of $76.04.

Shares of Colgate-Palmolive (CL) opened at $73.99 on Tuesday. Colgate-Palmolive has a 52-week low of $63.43 and a 52-week high of $77.27. The company has a debt-to-equity ratio of 24.42, a quick ratio of 0.92 and a current ratio of 1.23. The company has a market cap of $65,023.68, a P/E ratio of 25.80, a P/E/G ratio of 3.39 and a beta of 0.81.

In other Colgate-Palmolive news, Director Stephen I. Sadove sold 20,780 shares of the stock in a transaction on Monday, November 6th. The shares were sold at an average price of $70.52, for a total transaction of $1,465,405.60. Following the transaction, the director now directly owns 36,268 shares of the company’s stock, valued at $2,557,619.36. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, insider Victoria L. Dolan sold 10,000 shares of the stock in a transaction on Thursday, November 9th. The shares were sold at an average price of $73.07, for a total transaction of $730,700.00. Following the transaction, the insider now directly owns 60,528 shares in the company, valued at $4,422,780.96. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 181,048 shares of company stock worth $13,168,995. 1.02% of the stock is owned by company insiders.

Institutional investors and hedge funds have recently bought and sold shares of the business. Jacobi Capital Management LLC lifted its stake in shares of Colgate-Palmolive by 125.5% in the third quarter. Jacobi Capital Management LLC now owns 1,443 shares of the company’s stock worth $104,000 after buying an additional 803 shares in the last quarter. OLD Second National Bank of Aurora purchased a new position in shares of Colgate-Palmolive in the second quarter worth about $109,000. Krilogy Financial LLC lifted its stake in shares of Colgate-Palmolive by 23.0% in the second quarter. Krilogy Financial LLC now owns 1,547 shares of the company’s stock worth $115,000 after buying an additional 289 shares in the last quarter. Harbour Capital Advisors LLC purchased a new position in shares of Colgate-Palmolive in the first quarter worth about $121,000. Finally, Hanson & Doremus Investment Management lifted its stake in shares of Colgate-Palmolive by 4.5% in the second quarter. Hanson & Doremus Investment Management now owns 1,630 shares of the company’s stock worth $121,000 after buying an additional 70 shares in the last quarter. 72.96% of the stock is currently owned by institutional investors and hedge funds.

COPYRIGHT VIOLATION NOTICE: This report was originally reported by American Banking News and is the property of of American Banking News. If you are viewing this report on another publication, it was illegally stolen and republished in violation of international copyright & trademark law. The correct version of this report can be viewed at https://www.americanbankingnews.com/2017/12/19/colgate-palmolive-cl-expected-to-announce-quarterly-sales-of-3-91-billion.html.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.

Get a free copy of the Zacks research report on Colgate-Palmolive (CL)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.